Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-24 @ 11:43 PM
Study NCT ID:
NCT02642159
Status:
COMPLETED
Last Update Posted:
2018-05-01
First Post:
2015-12-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-15
Start Date Type:
None
Primary Completion Date:
2017-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-24
First Submit QC Date:
None
Study First Post Date:
2015-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-20
Results First Submit QC Date:
None
Results First Post Date:
2018-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-30
Last Update Post Date:
2018-05-01
Last Update Post Date Type:
ACTUAL